Selective activation of thyroid hormone signaling pathways by GC-1: A new approach to controlling cholesterol and body weight

Trends in Endocrinology and Metabolism

Volumn 15, Issue 4, 2004, Pages 154-157

  Baxter, John D ^a   Webb, Paul ^a   Grover, Gary ^a   Scanlan, Tom S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHOLESTEROL; ENZYME INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; ISOPROTEIN; LIPOPROTEIN; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYROTROPIN; TRIACYLGLYCEROL;

BODY WEIGHT; DRUG EFFICACY; HEART RATE; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN TRANSPORT; RECEPTOR BLOCKING; REVIEW; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ACETIC ACIDS; ANIMALS; ANTICHOLESTEREMIC AGENTS; BODY WEIGHT; CHOLESTEROL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPOPROTEINS; PHENOLS; SIGNAL TRANSDUCTION; THYROID HORMONE RECEPTORS ALPHA; THYROID HORMONE RECEPTORS BETA; THYROID HORMONES; WEIGHT LOSS;

EID: 1942453725     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2004.03.008     Document Type: Review

References (34)

1. Ribeiro R.C.J., et al. The nuclear hormone receptor gene superfamily. Annu. Rev. Med. 46:1995;443-453.
2. Xie W., Evans R.M. Orphan nuclear receptors: the exotics of xenobiotics. J. Biol. Chem. 276:2001;37739-37742.
3. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:2000;121-141.
4. McKenna N.J., et al. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20:1999;321-344.
5. Braverman L.E., Utiger R.D. Werner's and Ingbar's The Thyroid: A Fundamental and Clinical Text. 2000;Lippincott Williams & Wilkins.
6. Baxter J.D., et al. Selective modulation of thyroid hormone receptor action. J. Steroid Biochem. Mol. Biol. 76:2001;31-42.
7. Cooper D.S. Hyperthyroidism. Lancet. 362:2003;459-468.
8. Scanlan T.S., et al. Selective thyromimetics: tissue-selective thyroid hormone analogs. Curr. Opin. Drug Discov. Devel. 4:2001;614-622.
9. Refetoff S., et al. The syndromes of resistance to thyroid hormone. Endocr. Rev. 14:1993;348-399.
10. Chatterjee V.K. Resistance to thyroid hormone. Horm. Res. 4:(Suppl.):1997;43-46.
11. Forrest D., Vennstrom B. Functions of thyroid hormone receptors in mice. Thyroid. 10:2000;41-52.
12. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81:2001;1097-1142.
13. O'Shea P.J., Williams G.R. Insight into the physiological actions of thyroid hormone receptors from genetically modified mice. J. Endocrinol. 175:2002;553-570.
14. Yoshihara H.A., et al. An efficient substitution reaction for the preparation of thyroid hormone analogues. Bioorg. Med. Chem. 6:1998;1179-1183.
15. Chiellini G., et al. Improved synthesis of the iodine-free thyromimetic GC-1. Bioorg. Med. Chem. Lett. 10:2000;2607-2611.
16. Chiellini G., et al. Synthesis and biological activity of novel thyroid hormone analogues: 5′-aryl substituted GC-1 derivatives. Bioorg. Med. Chem. 10:2002;333-346.
17. Wagner R.L., et al. A structural role for hormone in the thyroid hormone receptor. Nature. 378:1995;690-697.
18. Darimont B.D., et al. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12:1998;3343-3356.
19. Wagner R.L., et al. Hormone selectivity in thyroid hormone receptors. Mol. Endocrinol. 15:2001;398-410.
20. Webb P., et al. Design of thyroid hormone receptor antagonists from first principles. J. Steroid Biochem. Mol. Biol. 83:2002;59-73.
21. Yoshihara H.A., et al. Structural determinants of selective thyromimetics. J. Med. Chem. 46:2003;3152-3161.
22. Ye L., et al. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1. J. Med. Chem. 46:2003;1580-1588.
23. Hennemann G., et al. Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr. Rev. 22:2001;451-476.
24. Trost S.U., et al. The thyroid hormone receptor-β-selective agonist GC-1 differentially affects plasma lipids and cardiac activity. Endocrinology. 141:2000;3057-3064.
25. Stephan Z.F., et al. Reduction of cardiovascular and thyroxine- suppressing activities of L-T3 by liver targeting with cholic acid. Biochem. Pharmacol. 43:1992;1969-1974.
26. Ichikawa K., et al. Mechanism of liver-selective thyromimetic activity of SK&F L-94901: evidence for the presence of a cell-type-specific nuclear iodothyronine transport process. J. Endocrinol. 165:2000;391-397.
27. Grover G.J., et al. Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3′-Triiodo-L-Thyronine (T3). Endocrinology. 145:2004;1656-1661.
28. Johnston T.P., et al. Potency of select statin drugs in a new mouse model of hyperlipidemia and atherosclerosis. Int. J. Pharmaceut. 229:2001;75-86.
29. Hiyoshi H., et al. Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: comparison with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors. J. Lipid Res. 41:2000;1136-1144.
30. Grover G.J., et al. Selective thyroid hormone receptor-β activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability. Proc. Natl. Acad. Sci. USA. 100:2003;10067-10072.
31. Bakker O., et al. Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene. Biochem. Biophys. Res. Commun. 249:1998;517-521.
32. Weiss R.E., et al. Thyroid hormone action on liver, heart, and energy expenditure in thyroid hormone receptor beta-deficient mice. Endocrinology. 139:1998;4945-4952.
33. Ongphiphadhanakul B., et al. Etidronate inhibits the thyroid hormone-induced bone loss in rats assessed by bone mineral density and messenger ribonucleic acid markers of osteoblast and osteoclast function. Endocrinology. 133:1993;2502-2507.
34. Schneider D.L., et al. Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen. J. Am. Med. Assoc. 271:1994;1245-1249.